Big Data in Pharmaceuticals – Thematic Research

Big Data in Pharma Market Overview

The global data and analytics market in the pharma sector was valued at $1.4 billion in 2020. The healthcare and pharmaceutical industries generate data in abundance from a multitude of sources including physician notes, pathology reports, electronic health records (EHR), patient registries, genomics, clinical trials, social media, wearable devices, and many more. The dataset in question is huge in both size and complexity, rendering traditional data management techniques inefficient for processing.

This big data in pharmaceuticals – thematic research report assesses how big data analytics, combined with other emerging technologies, can be used across the pharma value chain. It provides an overview of the current landscape, including healthcare, technology, regulatory, and macroeconomic trends, as well as key players, while also highlighting opportunities for the use of big data analytics in the future. Moreover, the report provides an analysis of big data-related deals, jobs, and social media activity, highlighting the impact of the COVID-19 pandemic, where relevant.

Big data and analytics market overview for pharma industry

For more insights on this report, download a free report sample

What are the key trends that will shape the big data space?

The key trends that will shape the big data space can be divided into four categories: healthcare trends, technology trends, regulatory trends, and macroeconomic trends.

Healthcare trends

The main healthcare trends that will impact the big data space are real-world data, the COVID-19 pandemic, clinical trial design & recruitment, increased use of digital technologies in clinical research, use of AI and big data in drug discovery, drug repurposing, & vaccine development, precision & personalized medicine, industry 4.0, wearables & the collection of health data, and sales & marketing.

Technology trends

Some of the main technology trends that will impact the big data space are cloud computing, 5G, and cybersecurity.

Regulatory trends

The main regulatory trends that will impact the big data space are data privacy & regulatory compliance, cures 2.0, and partnership with regulatory agencies.

Macroeconomic trends

The main macroeconomic trends that will impact the big data space are cost & rising healthcare demand, drug pricing, and the future of work.

What are the different big data value chains in the pharma industry?

The big data value chains in the pharma industry can be divided into three segments: big data generation, big data management, and big data product development.

Big data generation

In healthcare, data is primarily generated by sources such as hospitals, medical groups, and registries. This data is typically generated in the form of EHRs, which include patient health information such as administrative and billing data, demographics, vital signs, and medical history. Internally, the pharma industry can also generate copious amounts of data from clinical trials as well as from operations such as sales and manufacturing.

Big data management

Big data is typically managed in data centers, either in the public cloud, in corporate data centers, or on end devices. Broadly speaking, the objective of big data management is to secure the data (using data governance and security technology), gather insights from the data (using data analysis and business intelligence tools), and manage the data (by applying storage, processing, aggregation, and integration techniques).

Big data product development

Once the data is stored, processed, secured, and analyzed, it can be used within a raft of big data-powered products. By leveraging the wealth of molecular, clinical, and genomic data available, drug R&D can be optimized in the preclinical and clinical stages of development. From a commercial standpoint, data from registries and sales can inform decision-making on marketing and pricing. Finally, pharmaceutical manufacturing can be optimized with big data and IoT technologies including drones, digital twins, smart sensors, etc.

Who are the key public big data vendors in the pharma industry?

The key public big data vendors in the pharma industry are Amazon, International Business Machines, Microsoft, Oracle, and SAP SE.

Who are the key private big data vendors in the pharma industry?

The key private big data vendors in the pharma industry are Antidote Technologies, BenevolentAI, Deep Genomics, Deep Lens, Exscientia, Healx, Insilico Medicine, Lantern Pharma, and Medidata Solutions.

Market report scope

Scope

• Overview of the current and future use cases of big data analytics in the pharma industry, across the value chain.
• Insightful review of the healthcare, technology, regulatory, and macroeconomic trends. Each trend is independently researched to provide a qualitative analysis of its implications in the big data space.
• Reports of the revenue opportunity forecast in the data and analytical markets in the pharma industry from 2020 to 2025, spanning three technology segments and 49 geographical markets.
• Key players in the big data space, with a focus on technology providers and pharma adopters.
• Industry analysis of big data in the context of jobs in the pharma industry, use of real-world evidence in post-marketing studies, social media, and several pharma-specific case studies.
• Deals analysis: outline of key deals within the big data space over the past three years, including mergers and acquisitions, strategic partnerships, and funding.

Reasons to Buy

• Assess who the leading technology players are in the big data space, as well as leading pharma adopters.
• See examples of how pharma companies are integrating big data analytics into their value chains.
• Understand what trends are driving the big data space and challenges that exist for pharma in the space.
• See how the big data landscape is evolving, with a review of company activity including mergers and acquisitions (M&A), strategic partnerships, and funding deals, as well as job analysis.
• Assess the impact of COVID-19 on big data analytics.